Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750631 · ClinicalTrials.gov registry record · NA
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02750631 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 30 participants.
The verdict
NCT02750631, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Depressed patients miss a night of sleep (Wake Night), then sleep at predetermined times ending at their desired sleep time. Beginning the morning following their Wake Night, patients sit in front of a bright light, continuing morning bright light and specified sleep time for six weeks with weekly visits measuring depressive symptoms.
Interventions
- OTHER Triple Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02750631
The ClinicalTrials.gov registry entry for NCT02750631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Triple Therapy is the first listed.
NCT02750631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02750631 about?
NCT02750631 is a clinical study titled "Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression". Depressed patients miss a night of sleep (Wake Night), then sleep at predetermined times ending at their desired sleep time. Beginning the morning following their Wake Night, patients sit in front of a bright light, continuing morning bright light and specified sleep time for six weeks with weekly v...
What is the current status of trial NCT02750631?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02750631?
The interventions under investigation include: Triple Therapy (OTHER).
Who is sponsoring clinical trial NCT02750631?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.